Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryDiuretics for heart failureBeta-blockers for hypertensionBeta-blockers for hypertensionDiuretics for heart failureDiuretics for heart failureJunctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesisA meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokineticsDevices in the management of advanced, chronic heart failureCarvedilol in hypertension treatmentBeta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine modelLevosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVEThe selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptorsHeart Failure: Diagnosis, Management and UtilizationThird-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureSignaling effectors underlying pathologic growth and remodeling of the heartβ-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literatureNew advances in beta-blocker therapy in heart failureCholinergic activity as a new target in diseases of the heartA Review of the External Validity of Clinical Trials with Beta-Blockers in Heart FailureDrug therapy for heart failure in older patients-what do they want?Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseasesIdentification of gene signatures regulated by carvedilol in mouse heartLife and death of a cardiac calcium sparkBeta-blockers for hypertension.Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.Modeling the effects of β1-adrenergic receptor blockers and polymorphisms on cardiac myocyte Ca2+ handling.The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.Therapy: atenolol versus metoprolol tartrate--conflicting outcomes data.A review of carvedilol arrhythmia data in clinical trials.International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).Beta-blockers in the treatment of hypertension: new data, new directions.Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects.Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model.The beta1-adrenergic receptor mediates the pharmacogenetic interaction of the ACE D allele and beta-blockers.Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization.Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative).Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion.
P2860
Q22241786-1562A912-59C6-43CC-AF02-CE86560DB401Q24185944-5B42984D-3EBE-489C-9D98-12DCD1697F3BQ24201511-236E801D-86CC-4A58-BC8E-942FF5599A7DQ24202812-26FC4A98-9AAF-4411-A514-6B10B192D72AQ24203661-3001F327-7A90-4360-A588-05F30F4E9055Q24244710-27CB5010-2A15-41FD-B46F-7E4AACD60CCEQ24320070-EDD49F4C-5AB8-4C19-A039-FFFA7FA11C57Q24602122-FFD61FF6-798C-4F8D-BECB-DA387DECD682Q24630052-7C2BB379-E538-4086-9798-9D4AEE7369D7Q24642654-50EEC94A-C8EE-414C-B9F2-60B4DDF78275Q24646260-8CE31800-304A-4B75-A083-E019E6351ED3Q24650903-E4D7F3C1-2B31-4275-94F6-F9B29739EA72Q24670735-A407808A-325C-4796-93C2-DDE390E4555FQ26745543-8D1D95BC-92A1-4EFB-9CF3-512518D8111AQ26822825-131555D7-1A42-4A38-8F96-62B9C203B7CAQ26825154-125499C1-C8B3-4505-9700-C648A29A620FQ26861630-894FB3C3-1B8A-4CF8-9C06-052018C0CD21Q26865919-02CB71BE-6494-4427-AF64-3024FD6F942FQ27004543-24B81B5D-9B5B-4A6A-B6DC-C737961A131FQ28068618-0246ADC0-80DC-444C-B468-FABD45AA1542Q28083086-E140367A-3AC3-4E49-89BA-F364E7483C91Q28270431-73A2BDA4-E3B5-4198-98C5-A6ED4BF25CD4Q28387435-295DE3FF-B200-4958-81CD-CE40678F138FQ28681451-2025962B-45B5-4E1F-8D28-0F1CC4235A49Q30238911-9DCFA1F8-AAA8-4BF5-8C02-EBA460F50ACDQ30252338-8899E212-E8CA-4640-89AF-F247E9D802B8Q30371695-853B4DA7-B856-4E88-986D-E817F4A9FF7DQ30585014-648458AC-0406-436F-AB1A-029971AF1889Q30848706-54578724-F86C-434F-939D-937422F4EB6EQ30992419-5B865FE8-1D9A-4E9F-A27C-20A1E1BEC89AQ31064781-951D8E32-C5ED-425B-BD9E-0B722F345883Q31094492-2F840221-1B62-43B0-9611-180309713F6CQ31149036-51D2D259-DFE3-4C21-A484-BC0329862DFEQ33378995-472C19BB-B98E-4961-A7FD-E6342514105FQ33561456-16A7E1A0-4356-4E5B-B4CD-F15E2A742683Q33606538-8138768D-8AFA-4EE4-8FE4-B8A4F7AA157CQ33712648-31838E00-BF55-41E0-9BCE-EB916193A92AQ33715828-BB45CFF9-6E86-4DCE-BF05-DCF1D694BE84Q33726160-237D1D63-1099-4545-8717-54244332056CQ33735757-6F3B5038-DEB4-4ED5-9E2B-3E2E40A2B006
P2860
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Comparison of carvedilol and m ...... : randomised controlled trial.
@ast
Comparison of carvedilol and m ...... : randomised controlled trial.
@en
Comparison of carvedilol and m ...... l Or Metoprolol European Trial
@nl
type
label
Comparison of carvedilol and m ...... : randomised controlled trial.
@ast
Comparison of carvedilol and m ...... : randomised controlled trial.
@en
Comparison of carvedilol and m ...... l Or Metoprolol European Trial
@nl
prefLabel
Comparison of carvedilol and m ...... : randomised controlled trial.
@ast
Comparison of carvedilol and m ...... : randomised controlled trial.
@en
Comparison of carvedilol and m ...... l Or Metoprolol European Trial
@nl
P2093
P50
P1433
P1476
Comparison of carvedilol and m ...... : randomised controlled trial.
@en
P2093
Allan Skene
Andrea Di Lenarda
Armin Scherhag
Beatrix Lutiger
Carvedilol Or Metoprolol European Trial Investigators
Jacobus Lubsen
John G F Cleland
Peter Hanrath
Philip A Poole-Wilson
Willem J Remme
P356
10.1016/S0140-6736(03)13800-7
P407
P577
2003-07-01T00:00:00Z